Modernizing Part D and Medicare Advantage To Lower Drug Prices and Reduce Out-of-Pocket Expenses
medicare · Centers for Medicare and Medicaid Services · Rule · Published 2019-05-23 · Effective 2020-01-01 · 84 FR 23832
Document
Document number
2019-10521
Federal Register citation
84 FR 23832
CFR reference
42 CFR 422
Type
Rule
Action
Final rule.
Category
medicare
Sub-agency
Centers for Medicare and Medicaid Services
Publication date
2019-05-23
Effective date
2020-01-01
HHS docket
CMS-4180-F
Abstract
This final rule amends the Medicare Advantage (MA) program (Part C) regulations and Prescription Drug Benefit program (Part D) regulations to support health and drug plans' negotiation for lower drug prices and reduce out-of-pocket costs for Part C and D enrollees. These amendments will improve the regulatory framework to facilitate development of Part C and Part D products that better meet the individual beneficiary's healthcare needs and reduce out-of-pocket spending for enrollees at the pharmacy and other sites of care.